J. Moynard

Most-cited papers

1. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters.

   D. Laplaud, L. Berthelot, P. Miqueu, K. Bourcier +10 more

   2006Journal of Neuroimmunology21 citations

   Semantic Scholar

   Save

2. Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

   B. Tessoulin, P. Thomare, E. Delande, J. Moynard +17 more

   2017Annals of Hematology13 citations

   Semantic Scholar

   Save

3. Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.

   L. Berthelot, P. Miqueu, S. Pettré, M. Guillet +6 more

   2010Clinical Immunology4 citations

   Semantic Scholar

   Save

4. Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools

   W. Ammor, J. Moynard, F. Lindenberg, D. Navas

   2026European Journal of Clinical Pharmacology1 citations

   Semantic Scholar

   Save

5. Pharmaticians : bridging clinical pharmacy and health IT

   Julie Jalleau, J. Moynard, Erwin Gérard

   2026Journal de Pharmacie Clinique0 citations Open access

   Semantic Scholar

   Save

6. Reply to the letter regarding ‘Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools’

   W. Ammor, J. Moynard, F. Lindenberg, D. Navas

   2026European Journal of Clinical Pharmacology0 citations

   Semantic Scholar

   Save